Showing results (1261-1270 of 4,380) with videos related to

Sort By:
Pageof 438
ACS Medicinal Chemistry Letters|February 18, 2022
Design, Synthesis, and Biological Evaluation of Novel EGFR PROTACs Targeting Del19/T790M/C797S MutationHualin Zhang, Ruliang Xie, Hawaa Ai-Furas, et al.
ACS Medicinal Chemistry Letters|February 18, 2022
Antibacterial Activity of Metergoline Analogues: Revisiting the Ergot Alkaloid Scaffold for Antibiotic DiscoveryJarrod W Johnson, Michael J Ellis, Zoë A Piquette, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Novel Pyridazin-3(2H)-one-Based Guanidine Derivatives as Potential DNA Minor Groove Binders with Anticancer ActivityMaría Carmen Costas-Lago, Noemí Vila, Adeyemi Rahman, et al.
ACS Medicinal Chemistry Letters|March 18, 2022
Computational Prediction of the Binding Pose of Metal-Binding PharmacophoresJohannes Karges, Ryjul W Stokes, Seth M Cohen
ACS Medicinal Chemistry Letters|September 28, 2018
Reviving B-Factors: Retrospective Normalized B-Factor Analysis of c-ros Oncogene 1 Receptor Tyrosine Kinase and Anaplastic Lymphoma Kinase L1196M with Crizotinib and LorlatinibTed W Johnson, Rebecca A Gallego, Alexei Brooun, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
SAR of 4-Alkoxybenzoic Acid Inhibitors of the Trypanosome Alternative OxidaseAlejandro Meco-Navas, Godwin U Ebiloma, Ana Martín-Domínguez, et al.
ACS Medicinal Chemistry Letters|September 28, 2018
Selective PPARδ Modulators Improve Mitochondrial Function: Potential Treatment for Duchenne Muscular Dystrophy (DMD)Bharat Lagu, Arthur F Kluge, Effie Tozzo, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Investigation of Proposed Activity of Clarithromycin at GABAA Receptors Using [(11)C]Flumazenil PETPeter J H Scott, Xia Shao, Timothy J Desmond, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Discovery and Pharmacological Characterization of Novel Quinazoline-Based PI3K Delta-Selective InhibitorsKlemens Hoegenauer, Nicolas Soldermann, Frédéric Stauffer, et al.
ACS Medicinal Chemistry Letters|August 27, 2016
Selective AKR1C3 Inhibitors Potentiate Chemotherapeutic Activity in Multiple Acute Myeloid Leukemia (AML) Cell LinesKshitij Verma, Tianzhu Zang, Nehal Gupta, et al.
Pageof 438